v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
COSTS AND EXPENSES:        
Research and development $ 4,498,657 $ 4,627,636 $ 8,385,656 $ 9,260,830
General and administrative 2,936,867 1,401,053 5,190,095 3,127,391
Total costs and expenses 7,435,524 6,028,689 13,575,751 12,388,221
LOSS FROM OPERATIONS (7,435,524) (6,028,689) (13,575,751) (12,388,221)
OTHER INCOME:        
Interest income, net 481 659 911 3,021
Total other income 481 659 911 3,021
NET LOSS $ (7,435,043) $ (6,028,030) $ (13,574,840) $ (12,385,200)
BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE $ (1.22) $ (1.14) $ (2.22) $ (2.45)
DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE $ (1.22) $ (1.14) $ (2.22) $ (2.45)
Weighted Average Number of Shares Outstanding, Basic 6,110,124 5,276,380 6,110,125 5,046,427
Weighted Average Number of Shares Outstanding, Diluted 6,110,124 5,276,380 6,110,125 5,046,427

Source